At the news
? NEUTRALIMPACT 3/10 144 filed Apr 1, 2026 at 16:06 ET
Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to notify intent to sell up to 10,000 shares, valued at approximately $300,000 based on current market prices. This follows a series of prior stock option exercises and sales totaling over $1.15 million in the past two months.
- Reporting owner: Elizabeth E. Reed, Officer of Travere Therapeutics
- Shares proposed for sale: 10,000 common shares
- Approximate value of proposed sale: $300,000 (based on $30/share)
- Sale to be conducted through Morgan Stanley Smith Barney LLC
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access